We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Camping World
CWH
$358M
| $845K | ﹤0.01% |
123,767
-7,251
| -6% | -$74.7K |
|
2627
First Watch Restaurant Group
FWRG
$737M
| $838K | ﹤0.01% |
79,938
+5,458
| +7% | +$78.9K |
|
2628
Genie Energy
GNE
$384M
| $836K | ﹤0.01% |
59,129
+488
| +0.8% | +$6.92K |
|
|
CLDT
2629
Chatham Lodging
CLDT
$620M
| $836K | ﹤0.01% |
106,236
+743
| +0.7% | +$5.53K |
|
2630
CryoPort
CYRX
$808M
| $833K | ﹤0.01% |
100,616
-274,181
| -73% | -$2.48M |
|
2631
Gray Television
GTN
$400M
| $831K | ﹤0.01% |
191,485
+1,250
| +0.7% | +$5.87K |
|
2632
Akebia Therapeutics
AKBA
$327M
| $829K | ﹤0.01% |
596,599
+3,608
| +0.6% | +$4.96K |
|
2633
FuboTV Inc
FUBO
$254M
| $829K | ﹤0.01% |
87,627
-1,339
| -2% | -$26.5K |
|
2634
Cadiz
CDZI
$269M
| $825K | ﹤0.01% |
168,072
-134,410
| -44% | -$734K |
|
2635
First Internet Bancorp
INBK
$227M
| $822K | ﹤0.01% |
40,356
+19,991
| +98% | +$418K |
|
2636
Ironwood Pharmaceuticals
IRWD
$624M
| $819K | ﹤0.01% |
233,412
+93,925
| +67% | +$385K |
|
|
DSM
2637
BNY Mellon Strategic Municipal Bond Fund
DSM
$292M
| $818K | ﹤0.01% |
136,099
| – | – |
|
2638
Helen of Troy
HELE
$625M
| $815K | ﹤0.01% |
56,532
+308
| +0.5% | +$5.38K |
|
2639
Vanda Pharmaceuticals
VNDA
$322M
| $812K | ﹤0.01% |
117,502
-173,971
| -60% | -$1.34M |
|
|
IAUX
2640
i-80 Gold Corp
IAUX
$1.19B
| $807K | ﹤0.01% |
533,933
| – | – |
|
2641
Bridgewater Bancshares
BWB
$569M
| $806K | ﹤0.01% |
45,530
+268
| +0.6% | +$4.91K |
|
2642
Blend Labs
BLND
$409M
| $801K | ﹤0.01% |
471,111
+3,486
| +0.7% | +$7.45K |
|
2643
Civista Bancshares
CIVB
$588M
| $800K | ﹤0.01% |
35,116
-33,799
| -49% | -$783K |
|
2644
Spok Holdings
SPOK
$220M
| $799K | ﹤0.01% |
73,336
+518
| +0.7% | +$6.59K |
|
|
OLP
2645
One Liberty Properties
OLP
$543M
| $798K | ﹤0.01% |
37,207
+297
| +0.8% | +$6.6K |
|
2646
Inhibikase Therapeutics
IKT
$366M
| $794K | ﹤0.01% |
472,399
+393,740
| +501% | +$699K |
|
|
KEEL
2647
Keel Infrastructure Corp
KEEL
$2.9B
| $792K | ﹤0.01% |
404,991
| – | – |
|
2648
South Plains Financial
SPFI
$834M
| $791K | ﹤0.01% |
18,886
+2,394
| +15% | +$98.9K |
|
2649
Sierra Bancorp
BSRR
$546M
| $790K | ﹤0.01% |
23,277
+90
| +0.4% | +$3.15K |
|
2650
Fresenius Medical Care
FMS
$13.1B
| $788K | ﹤0.01% |
34,928
-885
| -2% | -$20.3K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.